The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirect Line Regulatory News (DLG)

Share Price Information for Direct Line (DLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 198.40
Bid: 198.40
Ask: 198.70
Change: 2.40 (1.22%)
Spread: 0.30 (0.151%)
Open: 197.70
High: 200.00
Low: 196.00
Prev. Close: 196.00
DLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Ageas SA/NV

19 Mar 2024 15:00

RNS Number : 4063H
Citadel Group
19 March 2024

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Full name of discloser:

Citadel Group

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

AGEAS SA/NV

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

18 March 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

DIRECT LINE INSURANCE GROUP PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

Common Stock

ISIN BE0974264930

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

651,326

0.34

4,473

0.00

(2) Cash-settled derivatives:

32,620

0.01

204,449

0.10

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

TOTAL:

683,946

0.36

208,922

0.11

Class of relevant security:

Common Stock

ISIN US00844W2089

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.00

0

0.00

(2) Cash-settled derivatives:

0

0.00

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

TOTAL:

0

0.00

0

0.00

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

Common

Buy Transaction

114

39.6800 EUR

Common

Buy Transaction

61

39.7000 EUR

Common

Buy Transaction

263

39.7100 EUR

Common

Buy Transaction

381

39.7400 EUR

Common

Buy Transaction

261

39.7500 EUR

Common

Buy Transaction

407

39.7600 EUR

Common

Buy Transaction

299

39.7700 EUR

Common

Buy Transaction

531

39.8000 EUR

Common

Buy Transaction

5

39.8050 EUR

Common

Buy Transaction

840

39.8100 EUR

Common

Buy Transaction

920

39.8200 EUR

Common

Buy Transaction

159

39.8250 EUR

Common

Buy Transaction

1,271

39.8300 EUR

Common

Buy Transaction

2,077

39.8400 EUR

Common

Buy Transaction

1,974

39.8500 EUR

Common

Buy Transaction

660

39.8600 EUR

Common

Buy Transaction

623

39.8700 EUR

Common

Buy Transaction

722

39.8800 EUR

Common

Buy Transaction

165

39.8900 EUR

Common

Buy Transaction

40

39.8950 EUR

Common

Buy Transaction

183

39.9000 EUR

Common

Buy Transaction

1,287

39.9100 EUR

Common

Buy Transaction

425

39.9200 EUR

Common

Buy Transaction

153

39.9300 EUR

Common

Buy Transaction

755

39.9400 EUR

Common

Buy Transaction

826

39.9500 EUR

Common

Buy Transaction

4

39.9550 EUR

Common

Buy Transaction

1,109

39.9600 EUR

Common

Buy Transaction

29

39.9700 EUR

Common

Buy Transaction

720

39.9800 EUR

Common

Buy Transaction

547

39.9900 EUR

Common

Buy Transaction

2,415

40.0000 EUR

Common

Buy Transaction

789

40.0100 EUR

Common

Buy Transaction

606

40.0200 EUR

Common

Buy Transaction

486

40.0300 EUR

Common

Buy Transaction

295

40.0400 EUR

Common

Buy Transaction

304

40.0500 EUR

Common

Buy Transaction

664

40.0600 EUR

Common

Buy Transaction

867

40.0700 EUR

Common

Buy Transaction

779

40.0800 EUR

Common

Buy Transaction

429

40.0900 EUR

Common

Buy Transaction

229

40.1000 EUR

Common

Buy Transaction

8,255

40.1400 EUR

Common

Buy Transaction

2

43.4400 USD

Common

Sell Transaction

25

39.6700 EUR

Common

Sell Transaction

317

39.6900 EUR

Common

Sell Transaction

431

39.7100 EUR

Common

Sell Transaction

205

39.7200 EUR

Common

Sell Transaction

2,888

39.7300 EUR

Common

Sell Transaction

165

39.7400 EUR

Common

Sell Transaction

440

39.7500 EUR

Common

Sell Transaction

340

39.7600 EUR

Common

Sell Transaction

151

39.7800 EUR

Common

Sell Transaction

1,318

39.7812 EUR

Common

Sell Transaction

14,498

39.7882 EUR

Common

Sell Transaction

199

39.7900 EUR

Common

Sell Transaction

2,261

39.8000 EUR

Common

Sell Transaction

930

39.8100 EUR

Common

Sell Transaction

742

39.8200 EUR

Common

Sell Transaction

778

39.8238 EUR

Common

Sell Transaction

467

39.8240 EUR

Common

Sell Transaction

422

39.8253 EUR

Common

Sell Transaction

796

39.8300 EUR

Common

Sell Transaction

293

39.8326 EUR

Common

Sell Transaction

177

39.8370 EUR

Common

Sell Transaction

1,558

39.8400 EUR

Common

Sell Transaction

752

39.8421 EUR

Common

Sell Transaction

2,764

39.8500 EUR

Common

Sell Transaction

1,772

39.8537 EUR

Common

Sell Transaction

3,465

39.8600 EUR

Common

Sell Transaction

941

39.8700 EUR

Common

Sell Transaction

1,877

39.8800 EUR

Common

Sell Transaction

2,073

39.8900 EUR

Common

Sell Transaction

406

39.9000 EUR

Common

Sell Transaction

731

39.9100 EUR

Common

Sell Transaction

682

39.9200 EUR

Common

Sell Transaction

319

39.9300 EUR

Common

Sell Transaction

571

39.9400 EUR

Common

Sell Transaction

1,322

39.9500 EUR

Common

Sell Transaction

1,105

39.9600 EUR

Common

Sell Transaction

363

39.9700 EUR

Common

Sell Transaction

301

39.9729 EUR

Common

Sell Transaction

890

39.9737 EUR

Common

Sell Transaction

303

39.9750 EUR

Common

Sell Transaction

183

39.9750 EUR

Common

Sell Transaction

537

39.9800 EUR

Common

Sell Transaction

609

39.9900 EUR

Common

Sell Transaction

1,167

40.0000 EUR

Common

Sell Transaction

1,248

40.0100 EUR

Common

Sell Transaction

74

40.0111 EUR

Common

Sell Transaction

122

40.0114 EUR

Common

Sell Transaction

364

40.0117 EUR

Common

Sell Transaction

123

40.0120 EUR

Common

Sell Transaction

1,238

40.0200 EUR

Common

Sell Transaction

403

40.0300 EUR

Common

Sell Transaction

403

40.0600 EUR

Common

Sell Transaction

476

40.0700 EUR

Common

Sell Transaction

2,021

40.1382 EUR

Common

Sell Transaction

3,369

40.1382 EUR

Common

Sell Transaction

10,043

40.1382 EUR

Common

Sell Transaction

3,428

40.1384 EUR

Common

Sell Transaction

57

43.6500 USD

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Common

CFD

Reducing short position

1,306

39.8453 EUR

Common

CFD

Increasing short position

525

39.8505 EUR

Common

CFD

Increasing short position

2,421

39.8577 EUR

Common

CFD

Increasing short position

600

39.8617 EUR

Common

CFD

Increasing short position

6,295

39.8705 EUR

Common

CFD

Increasing short position

4,750

39.8716 EUR

Common

CFD

Reducing short position

1,832

39.8724 EUR

Common

CFD

Reducing short position

782

39.8834 EUR

Common

CFD

Increasing short position

500

39.8840 EUR

Common

CFD

Reducing short position

783

39.8892 EUR

Common

CFD

Increasing short position

3,664

39.9029 EUR

Common

CFD

Reducing short position

162

39.9034 EUR

Common

CFD

Increasing short position

5,537

39.9166 EUR

Common

CFD

Increasing short position

8,415

39.9171 EUR

Common

CFD

Increasing short position

998

39.9319 EUR

Common

CFD

Increasing short position

3,019

39.9663 EUR

Common

CFD

Reducing short position

5,110

39.9750 EUR

Common

CFD

Reducing short position

289

39.9869 EUR

Common

CFD

Increasing short position

2,144

40.0442 EUR

Common

CFD

Increasing short position

329

40.0851 EUR

Common

CFD

Increasing short position

3,343

40.1040 EUR

Common

CFD

Increasing short position

13,221

40.1363 EUR

Common

CFD

Reducing short position

4,298

40.1400 EUR

Common

CFD

Increasing short position

1,726

40.1400 EUR

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

19 March 2024

Contact name:

Paula Santos

Telephone number*:

020 7645 9700

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETVKLBFZXLZBBE
Date   Source Headline
9th May 20245:15 pmRNSHolding(s) in Company
8th May 20242:00 pmRNSResult of AGM
8th May 20247:00 amRNSTrading Update for Q1 2024
2nd May 202411:30 amRNSSignificant Leadership Change
30th Apr 20242:15 pmRNSDirector/PDMR Shareholding
26th Apr 202412:00 pmRNSHolding(s) in Company
10th Apr 20247:00 amRNSDirect Line Group to appoint new CFO
9th Apr 20245:00 pmRNSDirector/PDMR Shareholding
9th Apr 20244:00 pmRNSHolding(s) in Company
8th Apr 20246:00 pmRNSDirector/PDMR Shareholding
8th Apr 20242:00 pmRNS2023 Solvency and Financial Condition Report
8th Apr 202412:00 pmRNSNotice of 2024 AGM
3rd Apr 202412:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20242:11 pmRNSForm 8.5 (EPT/RI)- Replacement of Direct Line
28th Mar 20246:15 pmRNSDirector/PDMR Shareholding
28th Mar 20246:00 pmRNSDirector/PDMR Shareholding
28th Mar 20248:15 amRNSAnnual Financial Report
27th Mar 20241:28 pmRNSForm 8.3 - Direct Line Insurance Group plc
26th Mar 20243:20 pmRNSForm 8.3 - Direct Line Insurance Group Plc
26th Mar 20242:06 pmRNSForm 8.3 - Direct Line Insurance Group plc
26th Mar 20241:49 pmRNSForm 8.3 - Direct Line Insurance Group PLC
26th Mar 20241:47 pmRNSForm 8.5 (EPT/RI)- Replacement of Direct Line
26th Mar 20241:43 pmRNSForm 8.3 - Direct Line Insurance Group plc
26th Mar 202411:23 amRNSForm 8.5 (EPT/NON-RI)-Direct Line Insurance Group
26th Mar 202411:14 amRNSForm 8.5 (EPT/RI)-DIRECT LINE INSURANCE GROUP PLC
26th Mar 202411:13 amRNSForm 8.5 (EPT/RI)-Direct Line Insurance Group plc
26th Mar 20247:29 amRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 20245:06 pmRNSDIRECT LINE _8.5 EPT NON-RI_UK_BOFASE_Replacement
25th Mar 20243:21 pmRNSForm 8.3 - Ageas SA/NV
25th Mar 20243:20 pmRNSForm 8.3 - Direct Line Insurance Group Plc
25th Mar 20243:12 pmRNSForm 8.5(EPT/RI)-Direct Line Insurance Group Amend
25th Mar 20243:06 pmRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 20243:00 pmRNSForm 8.3 - Ageas SA/NV
25th Mar 20243:00 pmRNSForm 8.3 - Direct Line Insurance Group PLC
25th Mar 20242:26 pmEQSForm 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
25th Mar 20242:20 pmRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 20242:17 pmRNSForm 8.3 -Direct Line Insurance Group plc
25th Mar 20242:08 pmRNSForm 8.3 - Ageas SA NV
25th Mar 20241:55 pmRNSForm 8.3 - Direct Line Insurance Group PLC
25th Mar 20241:26 pmRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 20241:10 pmRNSForm 8.5 (EPT/RI)- Replacement of Direct Line
25th Mar 202412:17 pmRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 202411:37 amRNSForm 8.5 (EPT/NON-RI)-Direct Line Insurance Group
25th Mar 202411:29 amRNSForm 8.5 (EPT/RI)-Direct Line Insurance Group plc
25th Mar 202411:29 amRNSForm 8.5 (EPT/RI)-DIRECT LINE INSURANCE GROUP PLC
25th Mar 202410:30 amRNSDIRECT LINE INSURANCE_8.5 EPT RI_UK_MLI
25th Mar 202410:29 amRNSDIRECT LINE INSURANCE_8.5 EPT NON-RI_UK_BOFASE
25th Mar 20249:18 amRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 20249:10 amRNSForm 8.5 (EPT/RI)- Direct Line Insurance Group plc
22nd Mar 20246:28 pmRNSResponse to Rule 2.8 termination announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.